Evidence map›Paper›PMID 42035215›Full record

ArticleCardio-oncology (London, England)2026

Neck adiposity on standard oncologic CT predicts radiation-induced carotid disease in oropharyngeal cancer.

Efthymios Triantafyllou, Dhawal S Bandrey, Bhumiben Patel, Patrik J Van-Bergen, Gabrielle N Mbagwu, Jennifer Shen, Taher K Kapadia, Juhee Song, Jun-Ichi Abe, Amy C Moreno and 9 more

Abstract read
In one paragraph

Article in Cardio-oncology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Efthymios Triantafyllou *Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd # 1451, Houston, TX, 77030, USA.
Dhawal S Bandrey *Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd # 1451, Houston, TX, 77030, USA.
Bhumiben PatelDepartment of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd # 1451, Houston, TX, 77030, USA.
Patrik J Van-BergenDepartment of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd # 1451, Houston, TX, 77030, USA.
Gabrielle N MbagwuDepartment of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd # 1451, Houston, TX, 77030, USA.
Jennifer ShenDepartment of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd # 1451, Houston, TX, 77030, USA.
Taher K KapadiaDepartment of Internal Medicine, The University of Texas at Houston, Houston, TX, USA.
Juhee SongDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jun-Ichi AbeDepartment of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd # 1451, Houston, TX, 77030, USA.
Amy C MorenoDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, US.
Mohamed A NaserDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, US.
Katherine A HutchesonDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, US.
David I RosenthalDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, US.
Shaden KhalafDepartment of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd # 1451, Houston, TX, 77030, USA.
Cezar IliescuDepartment of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd # 1451, Houston, TX, 77030, USA.
Anita DeswalDepartment of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd # 1451, Houston, TX, 77030, USA.
Elie MouhayarDepartment of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd # 1451, Houston, TX, 77030, USA.
Clifton D FullerDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, US.
Efstratios KoutroumpakisDepartment of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd # 1451, Houston, TX, 77030, USA. EKoutroumpakis@mdanderson.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBidirectional signaling between arteries and adjacent adipose tissue has been implicated in atherosclerosis progression; we sought to ascertain whether baseline neck adiposity could be associated in vivo with radiation therapy (RT) induced carotid artery disease (RICAD) and correlated endpoints.

objectivesTo evaluate whether neck adiposity at the time of cancer diagnosis is associated with the subsequent development of RICAD in patients with oropharyngeal cancer (OPC).

methodsPatients with OPC treated with RT at a tertiary center between 2005 and 2010 were identified. A validated deep learning algorithm was applied to pre-treatment neck CT scans to quantify adipose tissue at the C3 vertebral level.

resultsOf 231 patients, 91% were male and 97% white, with a median age of 57 (IQR 52–63) years at diagnosis. Mean BMI was 28.7 ± 4.86 kg/m². With a median follow-up of 14.3 years (IQR 9.9–16.3), 44% developed new or worsened carotid atherosclerosis, 6% carotid stenosis > 50% and 6.5% stroke/TIA, while 45% developed the composite endpoint. Approximately 39% died. In the multivariable analysis, neck adiposity area index was significantly associated with the composite event (subdistribution hazard ratio (sHR) 1.05 per unit increase, 95% CI 1.02–1.07, p < 0.001). Baseline use of antiplatelets and tumor subsite (tonsil vs. other than tonsil) were also associated with the composite endpoint, while skeletal muscle index and traditional vascular risk factors were not.

conclusionsPre-treatment neck adiposity area index measured at the C3 vertebral level on standard of care oncologic CT scans predicts RICAD in OPC survivors.

Indexed as

Artificial intelligenceCerebrovascular eventsDeep learning modelHead and neck cancerPerivascular fatRadiation therapy

Identifiers

PMID42035215
PMCPMC13248235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.